Grown Rogue International (GRUSF) Net Margin Growth (3y) (2012 - 2023)
Grown Rogue International (GRUSF) Net Margin Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1,620.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -98.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4,358.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1,235.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -100.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4,252.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -404.00 |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | -1,076.00 |
| Jul 31, 2023 | 8,997.00 |
| Apr 30, 2023 | 11,683.00 |
| Jan 31, 2023 | 16,600.00 |
| Jan 31, 2022 | 56,383.00 |
| Jul 31, 2021 | 21,299.00 |
| Apr 30, 2021 | 12,724.00 |
| Jan 31, 2021 | 27,952.00 |
| Aug 31, 2014 | -157,057.00 |
| Aug 31, 2013 | 10,684.00 |
| May 31, 2013 | 1,795.00 |
| Feb 28, 2013 | -19,782.00 |
| Aug 31, 2012 | 44,981.00 |
| May 31, 2012 | -63,311.00 |
| Feb 29, 2012 | -399,310.00 |